Pyrrolo[2,3-d]pyrimidine compounds
US7601727B2 · kind B2 · utility
11Cited by
18References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 27, 2007 |
| Grant date | Oct 13, 2009 |
| Priority date | — |
| Expiry date | Jul 27, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of the formulawherein R1, R2 and R3 are as defined above, which are inhibitors of the enzyme protein kinases such as Janus Kinase 3 and as such are useful therapy as immunosuppressive agents for organ transplants, xeno transplation, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes and complications from diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, Leukemia and other autoimmune diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.